(2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)butan-2-ol hydrochloride
1).Product name:Voriconazole pharmaceutical intermediate
2).CAS NO.:188416-35-5
3).MF:C16H14Cl2F3N5O
4).MW:420.2165
2).CAS NO.:188416-35-5
3).MF:C16H14Cl2F3N5O
4).MW:420.2165
5).Assay:more than 95%
6).Appearance:white to off-white powder
7).Stroage condition:preserve in tight,light-resistant containers.
7).Stroage condition:preserve in tight,light-resistant containers.
8).Packaging detail:1kg/5kg/10kg aluminum foil vacuum bag
9).Chemical method:positive reaction10).UV:Maximum absorption wavelength 243nm or 298nm,Min absorption wavelength 229nm
11).IR:The infrared spectrum concordant to thac of CK.
12).Related substance:Single know impurity: max 0.1%,single unknow impurity:max 0.1%, totall impurity:max 0.5%
12).Heavy metal:max0.001%
13).Loss of dry: max 0.5$
14).Laevoisomer :max 0.2%
15).Methylbenzen:max 0.089%